EP3744326

JANSSEN PHARMACEUTICA
Application Number
EP20169861A
Filing Date
Mar 30, 2016
Status
Granted And Under Opposition
Nov 3, 2023
Grant Date
Dec 6, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3744326B1 was granted on Dec 6, 2023 by Janssen Pharmaceutica The patent is currently Granted And Under Opposition.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ADVANZ PHARMA SERVICES UKSep 6, 2024ADMISSIBLE
APPLEYARD LEESSep 5, 2024ADMISSIBLE
HOFFMANN EITLE PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBSep 5, 2024ADMISSIBLE
STADA ARZNEIMITTELSep 5, 2024ADMISSIBLE
ELKINGTON AND FIFESep 4, 2024ADMISSIBLE
SANDOZSep 4, 2024ADMISSIBLE
STRAWMANSep 4, 2024ADMISSIBLE
ACCORD HEALTHCAREAug 28, 2024ADMISSIBLE
TEVA PHARMACEUTICAL INDUSTRIESAug 28, 2024ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionUS2011105536
N/A
OppositionWO2011053829
N/A
OppositionWO2016164218
N/A
OppositionUS2009163519
N/A

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.